Marshall Wace North America’s OrthoPediatrics KIDS Stock Holding History

Marshall Wace North America’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,435	Closed	-$460K	–	1617
2021 Q1	$460K	Buy	+9,435	New	+$453K	﹤0.01%	1219
2020 Q3	–	Sell	-28,755	Closed	-$1.26M	–	1348
2020 Q2	$1.26M	Buy	+28,755	New	+$1.29M	0.01%	703

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace North America's KIDS Position: Q2 2021 in Review

Marshall Wace North America sold out of OrthoPediatrics (KIDS) in Q2 2021, closing a stake of 9,435 shares — an estimated $460K sold.

Marshall Wace North America first reported a position in KIDS in Q2 2020 and held it in 2 quarters. The position peaked at $1.26M in Q2 2020. 138 funds tracked by Wall St. Rank hold KIDS as of Q2 2021.

Marshall Wace North America reported no remaining OrthoPediatrics position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 9,435 OrthoPediatrics shares in Q2 2021, an estimated $460K.
Marshall Wace North America first reported a position in OrthoPediatrics in Q2 2020 and held it in 2 quarters.
Marshall Wace North America's OrthoPediatrics position peaked at $1.26M in Q2 2020.
138 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.